These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36207570)

  • 1. Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy.
    Nemeth CL; Gӧk Ö; Tomlinson SN; Sharma A; Moser AB; Kannan S; Kannan RM; Fatemi A
    Neurotherapeutics; 2023 Jan; 20(1):272-283. PubMed ID: 36207570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
    Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
    PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
    Singh J; Khan M; Singh I
    Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
    Monternier PA; Singh J; Parasar P; Theurey P; DeWitt S; Jacques V; Klett E; Kaur N; Nagaraja TN; Moller DE; Hallakou-Bozec S
    J Inherit Metab Dis; 2022 Jul; 45(4):832-847. PubMed ID: 35510808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
    Weinhofer I; Forss-Petter S; Zigman M; Berger J
    Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy.
    Monternier PA; Parasar P; Theurey P; Gluais Dagorn P; Kaur N; Nagaraja TN; Fouqueray P; Bolze S; Moller DE; Singh J; Hallakou-Bozec S
    J Pharmacol Exp Ther; 2022 Aug; 382(2):208-222. PubMed ID: 35764327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
    Singh J; Khan M; Singh I
    J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.
    Turk BR; Nemeth CL; Marx JS; Tiffany C; Jones R; Theisen B; Kambhampati S; Ramireddy R; Singh S; Rosen M; Kaufman ML; Murray CF; Watkins PA; Kannan S; Kannan R; Fatemi A
    Ann Neurol; 2018 Sep; 84(3):452-462. PubMed ID: 30069915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy.
    Raas Q; Gondcaille C; Hamon Y; Leoni V; Caccia C; Ménétrier F; Lizard G; Trompier D; Savary S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):704-714. PubMed ID: 30769094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
    Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
    J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
    Kruska N; Schönfeld P; Pujol A; Reiser G
    Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.
    Ma CY; Li C; Zhou X; Zhang Z; Jiang H; Liu H; Chen HJ; Tse HF; Liao C; Lian Q
    Biomed Pharmacother; 2021 Nov; 143():112214. PubMed ID: 34560537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
    Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
    Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
    Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
    Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes.
    Matsukawa T; Asheuer M; Takahashi Y; Goto J; Suzuki Y; Shimozawa N; Takano H; Onodera O; Nishizawa M; Aubourg P; Tsuji S
    Neurogenetics; 2011 Feb; 12(1):41-50. PubMed ID: 20661612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy.
    Gong Y; Mu D; Prabhakar S; Moser A; Musolino P; Ren J; Breakefield XO; Maguire CA; Eichler FS
    Mol Ther; 2015 May; 23(5):824-834. PubMed ID: 25592337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery for X-linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long-chain fatty acids.
    Moser AB; Liu Y; Shi X; Schrifl U; Hiebler S; Fatemi A; Braverman NE; Steinberg SJ; Watkins PA
    J Cell Biochem; 2021 Oct; 122(10):1337-1349. PubMed ID: 34056752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M; Beeson C; Singh A; Singh I
    J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.